Suzhou Ribo Life Science Co

Suzhou Ribo Life Science Co., Ltd. is a biotechnology company that researches and develops novel therapeutics for cardiovascular, metabolic, renal, and liver diseases in mainland China and internationally. Its pipeline includes RBD4059 and RBD1119 for thrombotic diseases, RBD5044 for hypertriglyceridemia, RBD7022 for hypercholesterolemia, and RBD7007 and RBD2080 for renal diseases, among others. The company was incorporated in 2007 and is based in Kunshan, China.